COL6A2 antibody (C-Term)

Catalog No. ABIN629654

Product Details anti-COL6A2 Antibody

Target: COL6A2 (Collagen, Type VI, alpha 2 (COL6A2))

Binding Specificity: C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This COL6A2 antibody is un-conjugated

Application: Western Blotting (WB)

Specificity: Collagen Type VI Alpha 2 antibody was raised against the C terminal of COL6 A2

Purification: Purified

Immunogen: Collagen Type VI Alpha 2 antibody was raised using the C terminal of COL6 A2 corresponding to a region with amino acids ARRFVEQVARRLTLARRDDDPLNARVALLQFGGPGEQQVAFPLSHNLTAI

Application Details

Application Notes: WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

Collagen Type VI Alpha 2 Blocking Peptide, catalog no. 33R-1491, is also available for use as a blocking control in assays to test for specificity of this Collagen Type VI Alpha 2 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of COL0 2 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for COL6A2

Target: COL6A2 (Collagen, Type VI, alpha 2 (COL6A2))

Alternative Name: Collagen Type VI alpha 2 (COL6A2 Products)

Synonyms: PP3610 antibody, Col6a-2 antibody, collagen type VI alpha 2 chain antibody, collagen, type VI, alpha 2 antibody, COL6A2 antibody, col6a2 antibody, Tcur_3411 antibody, Col6a2 antibody

Background: COL6A2 is one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The protein contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in its gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy.

Molecular Weight: 46 kDa (MW of target protein)